GlassScriptPhysician profile
Matthew J Swiber
NPI 1730150541
$4,947.33
in general payments reported to CMS, 2019-2025
22 companies · $844 in 2025
The $844 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $486 · 2021: $783 · 2022: $396 · 2023: $297 · 2024: $436 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,577.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,580.85 | 2019-2025 | Proclaim, Eterna, Octrode |
| Pfizer INC. | $214.11 | 2019-2025 | |
| Daiichi Sankyo INC. | $204.00 | 2019 | |
| Abbvie INC. | $152.99 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $134.81 | 2019-2025 | Belbuca |
| Boston Scientific Corporation | $117.42 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Arbor Pharmaceuticals, INC. | $80.38 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $61.03 | 2025 | |
| Spr Therapeutics, INC | $55.73 | 2025 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $54.78 | 2019 | |
| Valinor Pharma, LLC | $42.32 | 2024-2025 | Movantik |
| Amgen INC. | $36.88 | 2019 | |
| Mdd US Operations, LLC | $28.19 | 2019 | |
| Allergan, INC. | $26.09 | 2019 | |
| Sentynl Therapeutics, INC. | $25.74 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $25.59 | 2019 | |
| Painteq LLC | $23.94 | 2024 | Painteq |
| Grt US Holding, INC. | $23.64 | 2022 | |
| Nevro Corp. | $17.80 | 2024 | Senza |
| Zyla Life Sciences, INC. | $15.38 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.30 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Swiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.